Rafael Holdings, Inc. announced that Dr. Rick Ewing has recently taken on the role of Head of Drug Discovery and will be responsible for expanding the research and development team and advancing the early-stage pipeline. On January 19, 2022, the Board of Directors of Rafael Holdings, Inc. (the Company") elected William Conkling, the Company's current Chief Commercial and Business Officer, as the Company's Chief Executive Officer, effective February 1, 2022 and Mr. Conkling will no longer serve in his role as Chief Commercial and Business Officer. Mimi Huizinga, Chief Medical Officer, will be leaving the company as of January 31, 2022, to pursue other opportunities.